We used to be able to see Apple infringing on its own patents, and now Apple is facing a lawsuit against a health technology startup called Omni MedSci, which claims that AppleWatch heart rate sensor patents infringe its patented technology.
Heart rate measurement is an integral part of Apple Watch users. At present, the measurement method adopted by Apple is photoelectric method, which can allow the device to measure the heart rate through the near-infrared LED light source and the corresponding receiver without invading the human body. It is a popular type on the market. Monitoring method.
(Photo from: Cult of Mac)
Omni MedSci filed a lawsuit in court on Friday, claiming to have met with Apple from 2014 to 2016, but the discussion on the cooperation has not progressed. Apple is still in the Apple Watch heart rate sensor when it knows the Omni patent. Infringement technology was implanted. So they filed a lawsuit in Texas demanding a permanent lock-up order for Apple-related products and demanding damages and litigation costs.
Omni said Apple Watch infringes four patents related to optical technology in wearable devices that describe the use of LED sensor technology to measure different parameters of a user's blood.
These technologies were invented by Islam and owned by Omni, and were awarded patents 9651533 and 9757040 in 2017 and 9861286 and 9885698 in 2018.
This patent litigation is common in the United States. The Omni MedSci company is owned by Mohammed Islam, which owns six companies and holds several patents in optics and laser technology. His patent holding company Cheetah Omni Lawsuits have been filed against companies including Fujitsu, Alcatel-Lucent, Huawei, Nokia and Siemens.
Interestingly, the lawsuit chosen by the company has always been regarded as a paradise for patent protection. The company was also described as a “typical patent company†by a Detroit news website in 2015. “They keep applying for patents. Drawing a lawsuit is like a performance art."
Doubtful
According to the lawsuit, as early as June 2014, Islam joined Dr. Michael O'Relly, a medical technology expert at Apple, and Apple Hardware Manager, Mike Hillman, earlier in the same year. (Michael Hillman) met to discuss related patent applications. Apple released the Apple Watch three months later, in September 2014. Hillman then invited Islam to visit another Apple team in February 2015, when the Apple Watch open booking window was less than two months. The litigation documents further pointed out that Greg Joswiak, vice president of marketing for Apple products, invited an Islamic and Apple team to discuss the upcoming technology in an e-mail sent on July 14, 2016. Then at the meeting on July 18th, Islam shared these patents with Apple employees. Since then, Islam has continued discussions with his unnamed Apple staff about his patent status.
In December 2017, Islam sent an email to Apple executive Rayleigh asking him to "recognize" the patents 9651533 and 9757040. The specific content of the email is unknown, but it is presumed that Islam asked to clarify whether these technologies have been adopted by Apple Watch. The complaint showed that although Raleigh replied to Islam’s e-mail question, the content disappointed Islam. Reilly wrote back: "We (Apple) do not want to receive any information about your intellectual property."
Islam’s timeline called in the complaint has doubts. Because Apple had completed the development of the Apple Watch heart rate sensor before its first meeting with Apple executives in 2014, this technology was introduced in detail at the unveiling ceremony of the Apple Watch device. So Apple's reliance on the Omni patent is questionable; but perhaps even more skeptical is that after Apple's conference, Islam revised his intellectual property.
Although Apple has not commented on the matter, the company is willing to meet with the founder of the startup, indicating that Apple will further research advanced sensor technology. As Islam describes in all four of his patents, lasers can collect blood signals more efficiently than traditional LEDs.
In particular, Islam's "Publishation No. 9885698" covers a non-invasive method of monitoring the blood glucose levels in patients, and there are rumors that Apple is studying the technology.
Although it is difficult to judge the final judgment of the case, the patent case has always been played for many years, and Apple obviously will not be affected immediately.
As the structural support and optical signal transmission pathway and medium, flexible substrates are playing ever-increasingly important roles in advanced optoelectronic display devices. The use of flexible substrates will significantly reduce the weight of flat panel displays and provide the ability to conform, bend or roll a display into any shape. Moreover, it will open up the possibility of fabricating displays by continuous roll processing, thus providing the basis for cost-effective mass production. Flexible substrate mainly used in thermoelectric refrigerator accessories, high-end car seats, car cold cup, car refrigerator, head display, car power, home appliances, medical devices, semiconductor chips, laser projection, optical device packaging in optical fiber communication and other fields.
Currently, there are mainly three types of candidates for flexible substrates: ultrathin glass, metal foil, and plastic (polymer) films. The raw material use for our flexible substrate is PE base double-sided copper clad with 0.3mm thickness. We are equipped with professional metal etching equipment and exposure development equipment. We use fine etching process and manufactures, we can guarantee that our etching flexible substrate can achieve double-sided etching of different graphics, alignment, neatly arranged, and no shedding, no incomplete, no pores, no inclusions and other appearance defects.
Etching Flexible Substrate,Double-Sided Etching,PE Base Double-sided Copper Clad Flexible Substrate
SHAOXING HUALI ELECTRONICS CO., LTD. , https://www.cnsxhuali.com